VA stroke study - Neurologist care is associated with increased testing but improved outcomes

被引:93
作者
Goldstein, LB
Matchar, DB
Hoff-Lindquist, J
Samsa, GP
Horner, RD
机构
[1] Duke Univ, Med Ctr,Ctr Clin Hlth Policy Res, Duke Ctr Cerebrovasc Dis, Stroke Policy Program, Durham, NC 27710 USA
[2] Duke Univ, Durham VA Med Ctr, Durham, NC USA
[3] Duke Univ, Dept Med Neurol, Durham, NC USA
[4] NINDS, Off Minor Hlth & Res, Bethesda, MD 20892 USA
关键词
D O I
10.1212/01.WNL.0000082724.77447.3A
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: VA Stroke Study (VASt) data were analyzed to determine whether neurologist management affected the process and outcome of care of patients with ischemic stroke. Methods: VASt prospectively identified patients with stroke admitted to nine VA hospitals (April 1995 to March 1997). Demographics, stroke severity (Canadian Neurologic Score), stroke subtype (Trial of ORG 10172 in Acute Stroke Treatment [TOAST] classification), tests/procedures, and discharge status (independent, Rankin less than or equal to 2, vs dead or dependent, Rankin 3 through 5) were compared between patients who were or were not cared for by a neurologist. Results: Of 1,073 enrolled patients, 775 (neurologist care, n = 614; non-neurologist, n = 161) with ischemic stroke were admitted from home. Stroke severity (Canadian Neurologic Score 8.7 +/- 0.1 vs 8.4 +/- 0.2; p = 0.44), TOAST subtype (p = 0.55), and patient age (71.4 +/- 0.4 vs 72.4 +/- 0.7; p = 0.23) were similar for neurologists and non-neurologists. Neurologists more frequently obtained MRI (44% vs 16%; p < 0.001), transesophageal echocardiograms (12% vs 2%; p < 0.001), carotid ultrasounds (65% vs 57%; p = 0.05), cerebral angiography (8% vs 1%; p = 0.001), speech (35% vs 18%; p < 0.001), and occupational therapy (46% vs 33%; p = 0.005) evaluations. Brain CT, transthoracic echocardiogram, 24-hour ambulatory ECG use, and hospitalization durations (18.2 +/- 0.8 vs 19.7 +/- 4.1 days; p = 0.725) were similar. Neurologists' patients were less likely to be dead (5.6% vs 13.5%; OR = 0.38; 95% CI 0.22, 0.68; p = 0.001) and less likely to be dead or dependent (46.1% vs 57.1%; OR = 0.64; 95% CI 0.45, 0.92; p = 0.019) at the time of discharge. The benefit remained after controlling for stroke severity and comorbidity (OR = 0.63; 95% CI 0.42, 0.94; p = 0.025). Conclusion: Neurologist care was associated with more extensive testing, but similar lengths of hospitalization and improved out comes.
引用
收藏
页码:792 / 796
页数:5
相关论文
共 22 条
[1]  
Asplund K, 1997, BMJ-BRIT MED J, V314, P1151
[2]   How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials [J].
Asplund, K ;
Berman, P ;
Blomstrand, C ;
Dennis, M ;
Erila, T ;
Garraway, M ;
Hamrin, E ;
Hankey, G ;
Ilmavirta, M ;
Indredavik, B ;
Kalra, L ;
Kaste, M ;
Langhorne, P ;
Rodgers, H ;
Sivenius, J ;
Slattery, J ;
Stevens, R ;
Svensson, A ;
Warlow, C ;
Williams, B ;
WoodDauphinee, S ;
Deleo, D ;
Drummond, A ;
Fogelholm, R ;
Lincoln, N ;
Palomaki, H ;
Strand, T ;
Wilhelmsen, L ;
Counsell, C ;
Fraser, H .
STROKE, 1997, 28 (11) :2139-2144
[3]   Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction [J].
Ayanian, JZ ;
Landrum, MB ;
Guadagnoli, E ;
Gaccione, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1678-1686
[4]   Thrombotic thrombocytopenic purpura associated with ticlopidine - A review of 60 cases [J].
Bennett, CL ;
Weinberg, PD ;
Rozenberg-Ben-Dror, K ;
Yarnold, PR ;
Kwaan, HC ;
Green, D .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (07) :541-544
[5]   Retrospective assessment of initial stroke severity - Comparison of the NIH Stroke Scale and the Canadian Neurological Scale [J].
Bushnell, CD ;
Johnston, DCC ;
Goldstein, LB .
STROKE, 2001, 32 (03) :656-660
[6]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]   Anticoagulants and antiplatelet agents in acute ischemic stroke - Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association) [J].
Coull, BM ;
Williams, LS ;
Goldstein, LB ;
Meschia, JF ;
Heitzman, D ;
Chaturvedi, S ;
Johnston, KC ;
Starkman, S ;
Morgenstern, LB ;
Wilterdink, JL ;
Levine, SR ;
Saver, JL .
NEUROLOGY, 2002, 59 (01) :13-22
[8]   THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE [J].
GENT, M ;
EASTON, JD ;
HACHINSKI, VC ;
PANAK, E ;
SICURELLA, J ;
BLAKELY, JA ;
ELLIS, DJ ;
HARBISON, JW ;
ROBERTS, RS ;
TURPIE, AGG .
LANCET, 1989, 1 (8649) :1215-1220
[9]   Retrospective assessment of initial stroke severity with the Canadian Neurological Scale [J].
Goldstein, LB ;
Chilukuri, V .
STROKE, 1997, 28 (06) :1181-1184
[10]   Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria [J].
Goldstein, LB ;
Jones, MR ;
Matchar, DB ;
Edwards, LJ ;
Hoff, J ;
Chilukuri, V ;
Armstrong, SB ;
Horner, RD .
STROKE, 2001, 32 (05) :1091-1096